Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Omeprazole on Gut Microbiota in Obesity and GERD
NCT07850960Phase 4Not yet recruiting
- Sponsor
- Federal State Budgetary Scientific Institution
- Start
- Sep 2026
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
A Phase 4 trial of omeprazole in gastroesophageal reflux disease (GERD), sponsored by Federal State Budgetary Scientific Institution. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
omeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT07850960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07850960.